Bone Disease in Primary Biliary Cirrhosis: Increased Bone Resorption and Turnover in the Absence of Osteoporosis or Osteomalacia
Open accessThe DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Abstract
The role of vitamin D in hepatic osteodystrophy was examined. Eleven unselected patients with primary biliary cirrhosis (PBC) were assessed for disorders of mineral and vitamin D metabolism. Six were not receiving supplementary vitamin D, and five were being treated with oral vitamin D (50,000 IU daily). Serum levels of 25-hydroxyvitamin D were normal in all patients receiving oral therapy and in 4 of 6 untreated patients. Levels of serum 1,25-dihydroxy vitamin D and 24,25-dihydroxyvitamin D were normal or near normal in all patients. Studies were repeated after 6 months of therapy with parenteral vitamin D 2 (100,000 IU i.m. monthly) in 7 patients. Initial bone histomorphometry revealed no evidence of osteomalacia or osteoporosis. However, the bone resorption surface of trabecular bone was increased. This abnormality was no longer present on repeat bone biopsies obtained after parenteral vitamin D therapy, and bone formation had decreased. In addition, trabecular bone volume remained normal in the face of the lower rate of bone formation. Increased bone resorption surface in the absence of osteoporosis or osteomalacia has not been previously described in PBC. Improvement in this bone parameter, associated with the finding of a decrease in the formation of bone and in hydroxyproline excretion in urine after parenteral vitamin D, suggests that increased turnover may be an early feature of the bone disease which complicates PBC and that parenteral vitamin D may retard the rate at which hepatic osteodystrophy develops in chronic cholestatic liver disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Tetracycline-based histological analysis of bone remodeling
Frost, H. M. (1969) · Calcified Tissue Research · doi:10.1007/bf02058664 · Cited by 1,111
Cited by
Kaplan, M. M. (1987) · New England Journal of Medicine · doi:10.1056/nejm198702263160907 · Cited by 1,959
Valproic acid hepatic fatalities. III. U.S. experience since 1986
Bryant, A. E., & Dreifuss, F. E. (1996) · Neurology · doi:10.1212/wnl.46.2.465 · Cited by 339
Eastell, R., Dickson, R. E., Hodgson, S. F., Wiesner, R. H., Porayko, M. K., Wahner, H. W., Cedel, S. L., Riggs, L. B., & Krom, R. A. F. (1991) · Hepatology · doi:10.1002/hep.1840140215 · Cited by 297
Bone disease in primary biliary cirrhosis: independent indicators and rate of progression
Menon, K. V. N., Angulo, P., Weston, S., Dickson, E. R., & Lindor, K. D. (2001) · Journal of Hepatology · doi:10.1016/s0168-8278(01)00144-1 · Cited by 180
Guañabens, N., Parés, A., Ros, I., Caballería, L., Pons, F., Vidal, S., Monegal, A., Peris, P., & Rodés, J. (2005) · Journal of Hepatology · doi:10.1016/j.jhep.2004.11.035 · Cited by 179
“suggested an increased bone turnover in absence of osteoporosis [6].”
BackgroundSchiefke, I. (2005) · World Journal of Gastroenterology · doi:10.3748/wjg.v11.i12.1843 · Cited by 156
Rouillard, S., & Lane, N. E. (2001) · Hepatology · doi:10.1053/jhep.2001.20533 · Cited by 125
Gonzalez-Calvin, J. L., Gallego-Rojo, F., Fernandez-Perez, R., Casado-Caballero, F., Ruiz-Escolano, E., & Olivares, E. G. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-0077 · Cited by 81
Osteoporosis in liver diseases and after liver transplantation
Hay, J. E. (2003) · Journal of Hepatology · doi:10.1016/s0168-8278(03)00143-0 · Cited by 72
“Histomorphometric studies have generally shown low bone formation ([10], #399, [50], #62, [51], #73, [52], #32) but some also show evidence of increasing bone turnover ([10], #399, [53], #341, [54], #305).”
BackgroundGuañabens, N., & Parés, A. (2010) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2010.05.030 · Cited by 71
Sodium fluoride prevents bone loss in primary biliary cirrhosis
Guañabens, N., Parés, A., del Rio, L., Roca, M., Gómez, R., Muñoz, J., & Rodés, J. (1992) · Journal of Hepatology · doi:10.1016/0168-8278(92)90066-x · Cited by 68
Diagnosis and Management of Cirrhosis-Related Osteoporosis
Santos, L. A. A., & Romeiro, F. G. (2016) · BioMed Research International · doi:10.1155/2016/1423462 · Cited by 66
Osteoporosis in primary biliary cirrhosis: pathogenesis and treatment
Parés, A., & Guañabens, N. (2008) · Clinics in Liver Disease · doi:10.1016/j.cld.2008.02.005 · Cited by 63
Management of osteoporosis in liver disease
Guañabens, N., & Parés, A. (2011) · Clinics and Research in Hepatology and Gastroenterology · doi:10.1016/j.clinre.2011.03.007 · Cited by 56
Boone, R. H., Cheung, A. M., Girlan, L. M., & Heathcote, E. J. (2006) · Digestive Diseases and Sciences · doi:10.1007/s10620-006-8015-x · Cited by 54
Early increase of bone resorption in patients with liver cirrhosis secondary to viral hepatitis
Corazza, G. R., Trevisani, F., Di Stefano, M., De Notariis, S., Veneto, G., Cecchetti, L., Minguzzi, L., Gasbarrini, G., & Bernardi, M. (2000) · Digestive Diseases and Sciences · doi:10.1023/a:1005568406664 · Cited by 53
“This assumption is not contradicted by finding a normal BMD in class A patients and suggests that, as in primary biliary cirrhosis (41), bone loss is preceded by a period during which only hallmarks of high resorption are detectable.”
BackgroundBone histomorphometric changes after liver transplantation for chronic cholestatic liver disease
Guichelaar, M. M., Malinchoc, M., Sibonga, J. D., Clarke, B. L., & Hay, J. E. (2003) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2003.18.12.2190 · Cited by 50
Treatment of bone disorders in liver disease
Parés, A., & Guañabens, N. (2006) · Journal of Hepatology · doi:10.1016/j.jhep.2006.06.007 · Cited by 50
“Increased resorption may also play a role in the development of osteoporosis in liver diseases [61,62].”
Background
Metadata
- Authors
- Cuthbert, J. A., Pak, C. Y. C., Zerwekh, J. E., Glass, K. D., & Combes, B.
- Venue
- Hepatology
- Published
- 1984-01
- Volume
- 4
- Issue
- 1
- Pages
- 1-8
- ISSN
- 0270-9139 (ISSN-L)
- OpenAlex
- W1985535194
- Cited by
- 116
- References
- 1
- FWCI
- 5.89
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.